CD4+ T cells from T-ICC were predominantly distributed at the terminal ends of the transition trajectory pathway, especially CD4 KLRB1 cells, mainly from T-ICC rather than P-ICC. The gene discussed is CD4; the disease is intrahepatic cholangiocarcinoma.